日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development

高迁移率族蛋白A1 (HMGA1) 转录组在癌症和发育中的作用

Sumter, T F; Xian, L; Huso, T; Koo, M; Chang, Y-T; Almasri, T N; Chia, L; Inglis, C; Reid, D; Resar, L M S

Hes1 Increases the Invasion Ability of Colorectal Cancer Cells via the STAT3-MMP14 Pathway

Hes1通过STAT3-MMP14通路增强结直肠癌细胞的侵袭能力

Weng, M T; Tsao, P N; Lin, H L; Tung, C C; Change, M C; Chang, Y T; Wong, J M; Wei, S C

Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial

患者报告的基于实践的减重机会(POWER)试验结果

Rubin, R R; Peyrot, M; Wang, N-Y; Coughlin, J W; Jerome, G J; Fitzpatrick, S L; Bennett, W L; Dalcin, A; Daumit, G; Durkin, N; Chang, Y-T; Yeh, H-C; Louis, T A; Appel, L J

Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis.

抑制糖原合成酶激酶-3可通过下调炎症和肾细胞凋亡来减少内毒素血症引起的急性肾衰竭

Wang Y, Huang W C, Wang C Y, Tsai C C, Chen C L, Chang Y T, Kai J I, Lin C F

Impact of enhanced infection control procedures on clinical outcome following resuscitation attempts

加强感染控制措施对复苏后临床结果的影响

Chuang, H-L; Leung, W-S; Chung, Y-T; Chang, Y-T; Chen, W-K